International studies are finding that Hyperbaric Oxygen Therapy (HBOT) is markedly superior to the routine treatment of RA. The Proceedings of the Eleventh International Congress on Hyperbaric Medicine published the results of one particular study that indicated the total summarized effective rate of hyperbaric oxygen in treating RA was 91.9%. The authors of the study concluded, “In the treatment we find that hyperbaric oxygen is markedly superior to the routine treatment of rheumatoid arthritis.”
Hyperbaric oxygen therapy has become a standard of practice for RA in many countries. Clinical practice has proven that hyperbaric oxygen therapy has positive effects on analgesia, lowering blood sedimentation rate, stabilizing immunologic function, and strengthening the body’s resistance for eliminating pathogenic factors. It is also beneficial for the repair of the diseased joints.
Hyperbaric oxygen therapy has actually been found to inhibit the development of the disease process. HBOT can suppress inflammation due either to immune factors or infection. Moreover, daily hyperbaric oxygen therapy suppresses the inflammatory response even if the disease is fully developed; however, the treatment of RA with hyperbaric oxygen therapy is more effective in the early stages of the disease.
Contact Thrive Hyperbarics today.
Copyright © 2024 Thrive Hyperbarics - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.